Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Erimos Pharmaceuticals Names Dr. Scott Mohrland as President and Chief Executive Officer
May 1st, 2007
Erimos Pharmaceuticals, a growing biopharmaceutical company focused primarily on the discovery, development and commercialization of small molecule therapeutics to treat cancer, today named its new President and CEO: J. Scott Mohrland, Ph.D. Dr. Mohrland is a pharmaceutical executive with more than 26 years of experience in the global pharmaceutical industry. His leadership has built and managed global organizations focused on the development and commercialization of oncology and other therapeutic products. Jeff Khoo, former Erimos CEO, will serve as Executive Vice Chairman on Erimos' board of directors, and will continue to provide leadership at the...
Source: Cancer Weekly (2007-05-01)
|
